The expression of the latter nerve growth factor receptor (CD271) and putative marker of melanoma initiating cells sufficiently mediated resistance to vemurafenib in vitro and was associated with lymph node metastasis in melanoma patients [2,3,4,5,6,7]. This evidence concerns the gene NGFR and metastatic malignant neoplasm in the lymph nodes.